New funding moves David Gamm’s retinitis pigmentosa treatment research into phase two
A grant from Fighting Blindness Canada will allow Dave Gamm to further test the efficacy of an induced pluripotent stem cell (iPSC) derived treatment that aims to replace damaged photoreceptor cells and restore some measure of vision.
December 7, 2021El CDC Publicó Nuevos Números de la Prevalencia de Autismo
English Por, Emily Leclerc, Escritora Científica, Waisman Center El reporte comunitario en autismo de los Centros para el Control y la Prevención de Enfermedades (CDC, en inglés) reveló que la prevalencia de autismo en niños …
December 6, 2021
Sonja Oetzel was recognized with the Pringle Award for her outstanding service at the Waisman Center
Sonja Oetzel’s friendly smile is the first thing most people see when they walk into the Waisman Center. Managing the front desk, Oetzel makes the Waisman Center a positive experience for visitors, and she was recognized for it with the 2021 University Staff Pringle Award.
November 22, 2021
Genetics has a higher influence on brain microstructure development than the environment
Brain structure isn’t always the first thing that comes to mind when we think about what we inherited from our biological parents or share with our siblings. We mostly think about facial features, hair color, and even personality.
November 17, 2021
Promising treatment for Alexander disease moves from rat model to human clinical trials
Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition.
November 17, 2021
Maria Nogueron is honored with the Wisconsin BPDD’s Diehard Award
Maria Nogueron, the UCEDD’s Constituent Advisory Committee (CAC) Chair at the Waisman Center, has been awarded the Wisconsin Board for People with Developmental Disabilities’ Diehard Award.
October 25, 2021
CMT biomarkers for future treatments
A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
October 19, 2021
Studying the connection between Alzheimer’s and Down syndrome for Down syndrome awareness month
By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of …
October 19, 2021
Stem cell project to create new model to study brain development and Down syndrome
Waisman Center researchers are creating a new approach to study how changes to brain development in the womb result in intellectual disability in people with Down syndrome.
October 11, 2021
UCEDD project to address health equity for Latino families of children with developmental disabilities
Padres e Hijos en Acción and the Waisman Center UCEDD announced a $330,000 grant to improve local health care responsiveness to the needs of Latino families of children with developmental disabilities and other special health care needs in Dane County.
June 14, 2021
Second seat in Waisman cluster hire filled by neuroscientist André Sousa
Sousa is the second hire in the cluster initiative that includes a biostatistician, a neuroscientist, and a geneticist.
May 24, 2021
Cengiz receives academic staff excellence awards
Pelin Cengiz, MD, an associate professor in the Department of Pediatrics and a Waisman Center investigator, is among this year’s recipients. She received the Chancellor’s Award for Excellence in Research: Independent Investigator.
April 27, 2021
Building community connection: from feedmill to autism therapy center
In the shadow of the Fennimore water tower sits a nondescript metal building. The once-abandoned former feed mill has now become The Learning Center, a unique resource for youth with autism and their families. Therapy …
April 25, 2021
The identities of enzymes: study further defines the function of a potential target for Alzheimer’s therapy
A new study from the lab of UW-Madison professor of medicine Luigi Puglielli, MD, PhD, opens a door to potential treatments for diseases of age, such as Alzheimer’s disease, by defining the roles of two enzymes that are imperative to protein production.
April 20, 2021
Artificial intelligence can accelerate clinical diagnosis of fragile X syndrome
An analysis of electronic health records for 1.7 million Wisconsin patients revealed a variety of health problems newly associated with fragile X syndrome.
April 9, 2021
Waisman CP Clinic strikes a balance
Twins Sebastian and Charlotte Sundly are quite the contrasting pair, yet they balance one another out perfectly in some interesting and unexpected ways.
March 29, 2021
Illuminating the brain through a new channel
A new study from the Binaural Hearing and Speech (BHS) Lab at the Waisman Center examines functional near-infrared spectroscopy (fNIRS) – a neuroimaging option that is safe for individuals with metal implants
March 16, 2021
A stimulating environment: Waisman Center acquires neuromodulation lab for infants and children
The adaptability of children with disabilities has inspired Bernadette Gillick, PhD, MSPT, PT for the majority of her career.
March 9, 2021
Individualized brain cell grafts reverse Parkinson’s symptoms in monkeys
Grafting neurons grown from monkeys’ own cells into their brains relieved the debilitating movement and depression symptoms associated with Parkinson’s disease, researchers at the University of Wisconsin–Madison reported today.
March 1, 2021UW vision researchers partner with U.S. Department of Defense to develop stem cell therapy for combat-related eye injuries
The new project, titled Outer Retina Reconstruction for Combat Afflictions or ORRCA, is a collaboration between the McPherson Eye Research Insitute at UW‒Madison, the UW School of Medicine and Public Health, the UW College of Engineering, the University of Birmingham (UK) and British Ministry of Defence and the National Eye Institute. It is funded by a grant for more than $5 million from the U.S. Department of Defense (DOD).
January 11, 2021
When research goes remote: adapting studies in the face of COVID-19
By Peter Jurich, Waisman Science Writer With every challenge comes new opportunities. When the COVID-19 pandemic hit the U.S. in March 2020, much of the country went on lock-down with only essential services and operations …
January 10, 2021Transformative gift supports scholars
The Morse Society, a group of Waisman graduate students and postdoctoral fellows, is getting a surprisingly early financial boost from its founders. Founded by Dick Morse, MD, a UW alum and retired child psychiatrist, and his lifelong partner, Lawrence M. Connor, MSW, a retired social worker, the Morse Society is focused on training and research in childhood mental health and developmental disabilities.
January 6, 2021- More 2021 posts
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.